Search research articles
Contact Us
Filters
Showing results (41-50 of 374) with videos related to
Page
of 38
Sort By:
Expert Opinion on Emerging Drugs
|
July 8, 2010
Emerging drugs for ovarian cancer
Domenica Lorusso, Antonella Pietragalla, Sara Mainenti, et al.
Expert Review of Anticancer Therapy
|
June 12, 2024
Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer
Renata Pacholczak-Madej, Michele Bartoletti, Lucia Musacchio, et al.
Drug Design, Development and Therapy
|
June 9, 2018
Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy
Domenica Lorusso, Elisa Tripodi, Giuseppa Maltese, et al.
Expert Opinion on Drug Safety
|
May 5, 2017
The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer
Domenica Lorusso, Caterina Fontanella, Giuseppa Maltese, et al.
Tumori
|
April 5, 2019
Short-course olanzapine to prevent delayed emesis following carboplatin/paclitaxel for gynecologic cancer: a randomised study
Luigi Celio, Gabriella Saibene, Stefano Lepori, et al.
Annals of Surgical Oncology
|
June 23, 2006
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study
Anna Fagotti, Gabriella Ferrandina, Francesco Fanfani, et al.
Journal of Gynecologic Oncology
|
October 29, 2015
A critical assessment on the role of sentinel node mapping in endometrial cancer
Giorgio Bogani, Antonino Ditto, Fabio Martinelli, et al.
Expert Opinion on Investigational Drugs
|
November 27, 2009
Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity
Domenica Lorusso, Sara Mainenti, Antonella Pietragalla, et al.
Expert Opinion on Investigational Drugs
|
February 21, 2023
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Ignace Vergote, Isabelle Ray-Coquard, Domenica Lorusso, et al.
Frontiers in Oncology
|
September 20, 2021
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment
Camilla Nero, Francesca Ciccarone, Antonella Pietragalla, et al.
Page
of 38
Search research articles
Search
Showing results (41-50 of 374) with videos related to
Sort By:
Page
of 38
Expert Opinion on Emerging Drugs
|
July 8, 2010
Emerging drugs for ovarian cancer
Domenica Lorusso, Antonella Pietragalla, Sara Mainenti, et al.
Expert Review of Anticancer Therapy
|
June 12, 2024
Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer
Renata Pacholczak-Madej, Michele Bartoletti, Lucia Musacchio, et al.
Drug Design, Development and Therapy
|
June 9, 2018
Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy
Domenica Lorusso, Elisa Tripodi, Giuseppa Maltese, et al.
Expert Opinion on Drug Safety
|
May 5, 2017
The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer
Domenica Lorusso, Caterina Fontanella, Giuseppa Maltese, et al.
Tumori
|
April 5, 2019
Short-course olanzapine to prevent delayed emesis following carboplatin/paclitaxel for gynecologic cancer: a randomised study
Luigi Celio, Gabriella Saibene, Stefano Lepori, et al.
Annals of Surgical Oncology
|
June 23, 2006
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study
Anna Fagotti, Gabriella Ferrandina, Francesco Fanfani, et al.
Journal of Gynecologic Oncology
|
October 29, 2015
A critical assessment on the role of sentinel node mapping in endometrial cancer
Giorgio Bogani, Antonino Ditto, Fabio Martinelli, et al.
Expert Opinion on Investigational Drugs
|
November 27, 2009
Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity
Domenica Lorusso, Sara Mainenti, Antonella Pietragalla, et al.
Expert Opinion on Investigational Drugs
|
February 21, 2023
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Ignace Vergote, Isabelle Ray-Coquard, Domenica Lorusso, et al.
Frontiers in Oncology
|
September 20, 2021
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment
Camilla Nero, Francesca Ciccarone, Antonella Pietragalla, et al.
Page
of 38